新しい結核診断検査の付加価値を理解する
Nimalan Arinaminpathy1, David Dowdy2
1MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London, Norfolk Place, London W2 1PG, UK.
Nature
|December 4, 2015
まとめ
新しい結核診断検査の評価は 精度だけでなく 付加的な価値に 焦点を当てる必要があります このアプローチでは 結核の感染を抑制するために 患者の行動や医療システムを考慮します
科学分野:
- 公衆衛生
- 感染症 疫学
- 医療診断
背景:
- 結核 (TB) は世界の主要な死因であり,診断されていない症例によって悪化しています.
- 現在の診断試験の評価では 結核の感染への影響が過大評価されている可能性があります
- 患者の要因と伝播ダイナミクスは,診断試験の有効性に影響します.
研究 の 目的:
- 新型結核診断検査の評価に変化を提案する.
- 結核の感染抑制における 診断検査の付加価値の定義と測定
- 集団レベルでの診断テストの影響を評価するための統一された枠組みを開発する.
主な方法:
- 新しく簡素化された結核感染モデルの開発
- 感度と特異性を超えた診断試験のインクリメンタル値の評価
- 患者の行動,病気の自然経歴,および健康システム要因の統合.
主要な成果:
- 新型の結核診断検査の 増加価値は 精度,患者の行動,病気の自然経歴,および健康システムによって影響されます.
- 予防された感染などの集団レベルでのアウトカムに基づいて診断テストの評価のための枠組みが提示されています.
- このモデルは,追加のデータが効果的な実施戦略にどのように役立つかを示しています.
結論:
- 新しい結核診断検査の評価には 人口レベルでのインクリメンタル・バリュー・フレームワークが不可欠です
- 診断試験の影響は,本質的な精度を超えた要因に左右されます.
- このアプローチは,結核の制御のための診断技術のより効果的な実施につながります.
関連する概念動画
Pulmonary Tuberculosis IV
699
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
699
Pulmonary Tuberculosis III
1.4K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.4K
Pulmonary Tuberculosis I
1.4K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.4K
Pulmonary Tuberculosis II
2.1K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.1K
Pulmonary Tuberculosis V
864
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
864
Automated Microbial Diagnostics
38
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
38


